Back to Journals » Drug Design, Development and Therapy » Volume 12

Original Research

Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-to-moderate hypertension: an 8-week, multicenter, randomized, open-label, Phase IV clinical study

       
Total article views   HTML views PDF downloads Totals
14,152 Dovepress* 12,236+ 946 13,182
PubMed Central* 1,916 305 2,221
Totals 14,152 1,251 15,403
*Since 19 December 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed and Google Scholar